|
Home | History | Meet the Team | In the News | Links | Store | Contact |
|
|
National Speakers
Association
LEGAL DISCLAIMER
|
GeriScan Geriatric Consulting PO Box 777 Clarks Summit, PA 18411 570.586.0655 |
Management of Alzheimer's Disease in LTC
LTC nurses will understand how to prevent decline in the ABC's of Alzheimer's disease (ADL, behavior, cognition) through adequate assessment, documentation, and medication treatment. Cholinesterase inhibitors used initially, followed by Memantine (Namenda) during the moderate and later stages of Alzheimer's disease is discussed. The LTC nurse will learn how to decrease or prevent use of antipsychotics by using optimal Alzheimer's treatment. The impact of Alzheimer's medication therapy on quality indicators, staff time, and cost of care is detailed.Management of Depression and Anxiety in LTC
This program presents reasons for prompt diagnosis and treatment of depression in LTC, including morbidity, mortality, functional decline, and increased risk for CVA and heart disease. The information will help attendees avoid survey citations regarding noncompliance at f-tag 319. The signs of depression related to state survey category deficiencies based on negative psychosocial outcomes are detailed. Depression assessment including vegetative signs, suicidal risk, the Geriatric Depression Scale, the Cornell scale for Depression in Dementia are covered. SSRI's, including Escitalopram (Lexapro) are compared. Geriatric profiling for safety, titration and effectiveness in depression and anxiety is reviewed. Depression management is related to the quality indicators.Assessment and Management of Alzheimer's Disease in Assisted Living Facilities
This program emphasizes the detection and management of Alzheimer's disease in the early, moderate and later stages. ALF staff will learn how to detect Alzheimer's through resident changes in function, behavior, mood and memory. The effects of cholinesterase inhibitors and Memantine are covered. The importance of early detection and treatment to improve resident quality of life and facility costs are discussed.Depression in Assisted Living Facilities
Depression and dementia are the top two reasons that ALF lose their residents to LTC.The relationship between depression, morbidity, mortality and functional status in ALF residents is explored. Depression assessment, including vegetative signs, suicidal risk, geriatric depression scales and depression in dementia is covered. Vascular depression is introduced. Antidepressant treatment is detailed, including geriatric doses, side effects, remission and maintenance therapy.
Roundtable Discussion of Depression and Dementia in LTC for Consultant Pharmacists
This program uses a problem-solving discussion format for consultant pharmacists to discuss their frustrations in dealing with resistance from prescribers regarding their written recommendations for depression, dementia and behavioral disturbances. Educational tools, books, websites, and research studies on depression and dementia are suggested to mobilize the entire multidisciplinary team to work with the new State Operations Manual Guidelines.Managing Behavioral Disturbances in Long-Term Care
Behavioral disorders in Alzheimer's and other dementias are defined and discussed. Classic symptoms of delirium and psychosis in dementia are detailed. The use of cholinesterase inhibitors and Memantine as a preventive strategy for behavioral problems is covered. Accurate documentation and non-pharmacologic strategies for behavioral disturbances are explored as weapons against citations for f-tag noncompliance with psychosocial outcomesAssessing the 3 D's (Dementia, Depression and Delirium)
Participants learn "quick and easy" dementia assessment tools. Instruments include the Folstein Mini-Mental State Exam, Confusion Assessment Method, Digit Spans, Clock Drawing, Time and Change tests, functional testing and others. Depression assessment reviews the vegetative signs of depression, functional changes of mild and major depression, the Geriatric Depression Scale and the Cornell Scale for Depression in Dementia. The participant learns to differentiate between dementia, depression, and delirium.Confused About Confusion: Atypical dementias and Alzheimer's
This presentation offers risk factors and symptoms of atypical dementias which are frequently seen in LTC residents, such as vascular dementia, dementia with Lewy bodies, Parkinson's dementia and frontotemporal dementias. The atypical dementias are differentiated from Alzheimer's disease. The participant learns the physical symptoms and typical behaviors of each type. Emphasis is placed on life-threatening issues, such as neuroleptic sensitivity. Management of Alzheimer's and atypical dementias based on current research is covered.